MDT and patient perspectives on the role of GLP-1 RAs in the T2D management pathway
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient explore the role of GLP-1 RAs in the T2D management pathway, real-world factors affecting selection of a GLP-1 RA, and how GLP-1 RA therapy has influenced real-life patients in their glycemic and weight-loss goals
The multidisciplinary team and patient
Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany
Primary Care Physician: Dr Kevin Fernando, Berwick, UK
Patient Advocate: Ms Kelly Ann Hardy, Margate, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.